BCL2L1 and prostate carcinoma: In turn, KEAP1 induced mitochondrial phosphoglycerate mutase 5 (PGAM5) expression, a protein serine/threonine phosphatase that degrades Bcl-xL (BCL2L1) present in the mitochondrial membrane [67], inducing apoptosis of prostate cancer cells.